Stacy J. Kanter
CIK 1775404 · last filed 2026-02-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$610.1K
Companies
2
Total Filings
16
Lifetime Open-Market Net
$504.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OPY | Director | 5,900 | $103.41 | $610.1K | $0 | 3 | 2026-02-27 |
| Applied Therapeutics, Inc. (APLT) Delisted | Director | 42,500 | $0.10 | $4.4K | $504.9K | 13 | 2026-02-04 |
Recent Filings · Page 2 of 2
16 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-07 | Applied Therapeutics, Inc. (APLT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | Applied Therapeutics, Inc. (APLT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-24 | Applied Therapeutics, Inc. (APLT) Delisted | Buy (P) | +6,500 | $148.6K | EDGAR |
| 2020-06-05 | Applied Therapeutics, Inc. (APLT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-29 | Applied Therapeutics, Inc. (APLT) Delisted | Buy (P) | +6,500 | $295.8K | EDGAR |
| 2019-05-15 | Applied Therapeutics, Inc. (APLT) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–16 of 16
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.